DIBIASE MARY (Chief Operating Officer) sold 0.9% of their position (2.64K shares) of X4 PHARMACEUTICALS, INC on the open market
Open‑market sale worth $1.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/11/2024ACC: 0001628280-24-040128
Officer· Chief Operating Officer
Since Sep 2021
-2.64K
Net shares
Net seller
$1.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.64K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.64K
Price / share
$0.66
Trade value
$1.74K
% of position
0.9%
9/9/2024
291.75K→289.11K
Total
Net shares
−2.64K
Net value
-$1.74K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/9/2024 | S · Sale | −2.64K | $0.66 | $1.74K | 0.9% | 291.75K | 289.11K |
| Total | −2.64K | -$1.74K | ||||||
Derivative Transactions0
No derivative transactions reported